Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Inspire Medical Systems
MedTech
Nyxoah plans US debut of OSA implant, as rival lobs patent suit
Nyxoah’s neuromodulation therapy for obstructive sleep apnea has claimed FDA approval—but its U.S. rollout may hit a legal roadblock.
Conor Hale
Aug 13, 2025 11:00am
Inspire Medical discloses DOJ civil false claims investigation
Feb 11, 2025 3:00pm
FDA amplifies Inspire's sleep apnea nerve stimulator recall
Jul 9, 2024 12:00pm
FDA label update eases access to Inspire's sleep apnea implant
Jun 13, 2023 11:26am
Inspire files for $75M IPO to step up sleep apnea sales drive
Apr 25, 2018 3:36am
